Sign inJoin waitlistJoin the waitlist

Michael Menefee

Physician · Cleveland Clinic

Credentials: · · · · · · ·

History

Cleveland Clinic
2024–Present

National Institutes of Health
2004–2006
Mayo Clinic
1999–2002
Boston University School of Medicine
Meharry Medical College
1995–1999
North Carolina A&T State University
1989–1993

Research

Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study
The Lancet Oncology · 2010 · 324 citations
Mechanisms of multidrug resistance: the potential role of microtubule-stabilizing agents
Review · Annals of Oncology · 2007 · 176 citations
A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer
The Journal of Clinical Endocrinology & Metabolism · 2012 · 134 citations

Charles Erlichman
11 papers
Keith Bible
11 papers
RS
Robert Smallridge
9 papers
Julian Molina
6 papers
Nina Karlin
6 papers · 3 as a fellow
JM
John Morris
5 papers
KS
Kostandinos Sideras
5 papers
WM
William Maples
5 papers
AT
Anne Traynor
4 papers
BI
Bryan Mc Iver
4 papers
Donald Northfelt
3 papers
IH
Ian Hay
3 papers

Clinical trials

Auranofin and Sirolimus in Treating Patients With Advanced Solid Tumors or Recurrent Non-Small Cell Lung Cancer
Study chair · Withdrawn · Phase 1
Mayo Clinic
2013
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2020–2027